RT Journal Article
SR Electronic
T1 Which traits predict elevated distress during the Covid-19 pandemic? Results from a large, longitudinal cohort study with psychiatric patients and healthy controls
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.04.01.21254625
DO 10.1101/2021.04.01.21254625
A1 Brosch, Katharina
A1 Meller, Tina
A1 Pfarr, Julia-Katharina
A1 Stein, Frederike
A1 Schmitt, Simon
A1 Ringwald, Kai G.
A1 Waltemate, Lena
A1 Lemke, Hannah
A1 Thiel, Katharina
A1 Schrammen, Elisabeth
A1 Hülsmann, Carina
A1 Meinert, Susanne
A1 Dohm, Katharina
A1 Leehr, Elisabeth J.
A1 Opel, Nils
A1 Krug, Axel
A1 Dannlowski, Udo
A1 Nenadić, Igor
A1 Kircher, Tilo
YR 2021
UL http://medrxiv.org/content/early/2021/04/05/2021.04.01.21254625.abstract
AB Background The Covid-19 pandemic resulted in repeated, prolonged restrictions in daily life. Social distancing policies as well as health anxiety are thought to lead to mental health impairment. However, there is lack of longitudinal data identifying at-risk populations particularly vulnerable for elevated Covid-19-related distress.Methods We collected data of N=1268 participants (n=622 healthy controls (HC), and n=646 patients with major depression, bipolar disorder, schizophrenia or schizoaffective disorder) at baseline (2014-2018) and during the first lockdown in Germany (April-May 2020). We obtained information on Covid-19 restrictions (number and subjective impact of Covid-19 events), and Covid-19-related distress (i.e., subjective fear and isolation). Using multiple linear regression models including trait variables and individual Covid-19 impact, we sought to predict Covid-19-related distress.Results HC and patients reported similar numbers of Covid-19-related events, and similar subjective impact rating. They did not differ in Covid-19-related subjective fear. Patients reported significantly higher subjective isolation. 30.5% of patients reported worsened self-rated symptoms since the pandemic. Subjective fear in all participants was predicted by four variables: trait anxiety (STAI-T), conscientiousness (NEO-FFI), Covid-19 impact, and sex. Subjective isolation in HC was predicted by social support (FSozu), Covid-19 impact, age, and sex; in patients, it was predicted by social support and Covid-19 impact.Conclusion Our data shed light on differential effects of the pandemic in psychiatric patients and HC. They identify relevant, easy-to-obtain variables for risk profiles related to interindividual differences in Covid-19-related distress for direct translation into clinical practice.Competing Interest StatementBiomedical financial interests or potential conflicts of interest: Tilo Kircher received unrestricted educational grants from Servier, Janssen, Recordati, Aristo, Otsuka, neuraxpharm. All other authors declare no conflict of interest.Funding StatementThis work is part of the German multicenter consortium Neurobiology of Affective Disorders. A translational perspective on brain structure and function, funded by the German Research Foundation (Deutsche Forschungsgemeinschaft DFG; Forschungsgruppe/Research Unit FOR2107). Tilo Kircher (speaker FOR2107; DFG grant numbers KI 588/14-1, KI 588/14-2, KI 588/15-1, KI 588/17-1), Udo Dannlowski (co-speaker FOR2107; DA 1151/5-1, DA 1151/5-2, DA 1151/6-1), Axel Krug (KR 3822/5-1, KR 3822/7-2), Igor Nenadic (NE 2254/1-2). Nils Opel received funding from the Interdisciplinary Centre for Clinical Research, IZKF, University of Muenster, Germany, Grant IZKF SEED 11/19Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the ethics committees of the universities of Marburg and Muenster, Germany, in accordance with the Declaration of Helsinki. The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available from the corresponding author on reasonable requests.